Merck pays J&J $500mn in drug row settlement
Friday, April 15, 2011 - 10:00
in Health & Medicine
Merck said Friday it has agreed to pay fellow US pharmaceutical giant Johnson & Johnson $500 million to end a two-year tussle over profit-sharing deals for two anti-inflammatory drugs.